MWA
SYNH

Marshall Wace Asia’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Marshall Wace Asia’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-32,330
Closed -$2.2M – 206
2020
Q4 		$2.2M Buy
+32,330
New +$2.02M 0.04% 117

Other funds holding SYNH

AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
THLTP
Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Marshall Wace Asia's SYNH Position: Q1 2021 in Review

Marshall Wace Asia sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2021, closing a stake of 32,330 shares — an estimated $2.2M sold.

Marshall Wace Asia first reported a position in SYNH in Q4 2020 and held it in 1 quarter. The position peaked at $2.2M in Q4 2020. 319 funds tracked by Wall St. Rank hold SYNH as of Q1 2021.

  • Marshall Wace Asia reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2021 after selling out during the quarter.
  • Marshall Wace Asia sold 32,330 Syneos Health, Inc. Class A Common Stock shares in Q1 2021, an estimated $2.2M.
  • Marshall Wace Asia first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2020 and held it in 1 quarter.
  • Marshall Wace Asia's Syneos Health, Inc. Class A Common Stock position peaked at $2.2M in Q4 2020.
  • 319 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2021.

Based on Marshall Wace Asia's 13F filing for Q1 2021, filed 17 May 2021.